Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cambria Gold Mines Announces Development and Construction Update at Red Mountain and Premier Gold Projects, Additions to Engineering Team and Warrants Exercised To-date
-
Terra Clean Energy Contracts KB Drilling for 10,000 Foot Core Drilling Program at Historic Marysvale Uranium Mine Project, Utah, United States
-
New Flyer secures additional order of 100 transit buses for Washington Metro
-
Goldera Expands High-Grade E1 Gold Discovery with Two New Parallel Structures Ahead of Planned Q4 Drilling at Egan Gold Project
-
Globaltech Corporation Confirms Establishment of Independent Audit, Compensation, and Nominating & Corporate Governance Committees
-
Apriem Advisors' Chris Whitaker Named to Forbes Best-In-State Next-Gen Advisors List
-
Canadian Goldfields Advances Systematic Exploration and Target Development at Miminiska Gold Project
-
Dynacor Reports First Gold from Senegal
-
Globaltech Corporation Confirms Establishment of Independent Audit, Compensation, and Nominating & Corporate Governance Committees
-
Nexus Advanced Technologies Announces Anson Note and Warrant Restructuring Agreement with Anson Funds
-
Vireo Growth Inc. Announces Financing for New York and Florida Cultivation Facility
-
BBP-418 Demonstrates Potential to Be Disease Modifying Therapy, Restoring Cardiac and Disease Markers to Unaffected Levels
-
Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors
-
Stardust Power Expands U.S. Operations with New Houston Office to Support Muskogee Refinery Build
-
Apriem Advisors' Chris Whitaker Named to Forbes Best-In-State Next-Gen Advisors List
-
Consensus estimates on Tryg A/S
-
Form 8.5 (EPT/RI)-Advanced Medical Solutions Group plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - TATE & LYLE PLC - Ordinary Shares
-
Form 8.5 (EPT/RI)-Gooch & Housego plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - STHREE PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - RHI MAGNESITA NV - Ordinary Shares
-
Jiuzi Holdings’ AI Smart Imaging Platform Accelerates Toward Completion: Enterprise-Grade Solution Nears Commercialization; Million-Dollar Profit Expectation Opens New Growth Space
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PHAROS ENERGY PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - GAMMA COMMUNICATIONS PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - CAPRICORN ENERGY PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DCC Energy PLC - Ordinary Shares
-
FIERCE BIOTECH NAMES REPRONOVO A “FIERCE 15” BIOTECH COMPANY OF 2026
-
Gilat Awarded $28 Million Contract to Expand Connectivity in Peru
-
Kraig Biocraft Laboratories Ramps Full Production Across All Three Production Centers as Commercial Deliveries Begin to Take Hold
-
Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders
-
61/2026・Trifork Group: Weekly report on share buyback
-
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Heineken N.V. reports the progress of transactions under its current share buyback programme
-
Patrick Tsang Brings Empulser to AIBotics in Definitive Defense-Technology Transaction
-
Harrow Closes Acquisition of TYRVAYA®
-
Baker Hughes Signs Two Agreements to Develop Venezuela's Natural Gas and Energy Infrastructure
-
Aldebaran Reports 1,728.9 m of 0.45% CuEq (0.41% Cu, 0.03 g/t Au & 1.34 g/t Ag), including 756 m of 0.68% CuEq (0.61% Cu, 0.03 g/t Au & 2.12 g/t Ag) at the Altar Copper-Gold Project in San Jua
-
BioCryst Announces Formation of Scientific Advisory Board to Drive Rare Disease Pipeline Innovation and Growth
-
Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences
-
Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial
-
Americold Realty Trust, Inc. Sets Date for Third Quarter 2026 Earnings Release and Conference Call
-
Electra Appoints General Manager to Lead Cobalt Refinery Commissioning and Operations
-
TurboGen Announces New Agreement with Leading Engineering and Manufacturing Company for Serial Development and Manufacturing of Its 20kW Systems for the Defense and Civilian Markets
-
Baker Hughes Signs Two Agreements to Develop Venezuela's Natural Gas and Energy Infrastructure
-
VisionWave Outlines Development of Autonomous Defense Ecosystem Across Tactical UAV and Counter-UAS Applications
-
Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism
-
Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases
-
DV Launches Attribution Measurement and Advances Brand Suitability for ChatGPT Ads
-
Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine
-
AIMS Surpasses 185,000 Global Active Traders, Solidifying Its Position as a Leading Regulated Prime Broker
